Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent metabolic and bariatric surgery, according to study results published in JAMA Surgery.
Adults who fasted 3 nonconsecutive days a week lost more weight vs. those assigned to daily calorie restriction.
Adults with obesity who used medication and received guidance on resistance training and nutrition lost substantially more fat mass than muscle mass, researchers reported in data that will be presented at the European Congress on Obesity.
Eli Lilly said its experimental drug, orforglipron, helped people with Type 2 diabetes lower their blood sugar and lose weight.
Adding an anti-obesity medication alongside behavioral therapy produced significantly more weight loss in patients who initially struggled with the therapy, a study in Nature Medicine showed.
